Tag: biomedical
-
AI-Designed Cancer Vaccine Shown to Act Against Melanoma
Results of a small clinical trial show most patients with melanoma receiving a personalized therapeutic vaccine with an approved immunotherapy reduced at least some of their tumors.
-
Low-Dose Oral Film Reduces Mental Disorder Agitation
Interim results from a clinical trial show a drug given as a dissolvable oral film in a lower dose reduces agitation in people with bipolar disorder and schizophrenia.
-
Pharma Company Gains Precise Gene Edits in $2B Biotech Deal
A global drug maker is acquiring access to a biotechnology company’s precise genome editing techniques to develop new therapies for rare and cardiometabolic disorders.
-
Safer Forms of Psilocybin Assessed in Preclinical Study
A biotechnology company says it identified engineered precursors of a psychedelic compound that in lab animals produce safe and intended therapeutic effects.
-
$60M Challenge Seeks Biomarkers, Models to Counter Aging Stress
A new challenge competition seeks biomarkers, models, and clinical tests of the factors behind responses to stress conditions in human aging that can stave off frailty or death.
-
Brain-Computer Device Company Gains $33M in Early Funds
A company creating brain-computer interface devices to help people with disabling communications impairments is raising $33 million in its first venture round.
-
Measles-Rubella Patch Vaccine Shown Effective as Injection
A clinical trial shows a peel-and-stick patch device is as effective as a standard syringe injection in delivering a vaccine that protects against measles and rubella.
-
Biotech, Janssen Partner on Ultrasound for Gene Therapy
A developer of ultrasound bubbles to assist gene therapies is studying use of the technology with Janssen Pharmaceuticals for delivering DNA and RNA treatments.
-
Rare Disease Search Adds Large Language Model A.I.
A company offering a search engine to help diagnose rare diseases is integrating generative models from Open AI into its artificial intelligence algorithms.
-
Collaboration to Boost Rare Disease Clinical Trials
An organization seeking new uses for today’s drugs and a contract research company aim to increase the number of clinical trials for rare diseases testing already approved drugs.